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Abstract
The N-glycans of membrane glycoproteins are mainly exposed to the extracellular space. Human tyrosinase is a
transmembrane glycoprotein with six or seven bulky N-glycans exposed towards the lumen of subcellular organelles. The
central active site region of human tyrosinase is modeled here within less than 2.5 A ˚ accuracy starting from Streptomyces
castaneoglobisporus tyrosinase. The model accounts for the last five C-terminus glycosylation sites of which four are
occupied and indicates that these cluster in two pairs - one in close vicinity to the active site and the other on the opposite
side. We have analyzed and compared the roles of all tyrosinase N-glycans during tyrosinase processing with a special focus
on the proximal to the active site N-glycans, s6:N337 and s7:N371, versus s3:N161 and s4:N230 which decorate the opposite
side of the domain. To this end, we have constructed mutants of human tyrosinase in which its seven N-glycosylation sites
were deleted. Ablation of the s6:N337 and s7:N371 sites arrests the post-translational productive folding process resulting in
terminally misfolded mutants subjected to degradation through the mannosidase driven ERAD pathway. In contrast, single
mutants of the other five N-glycans located either opposite to the active site or into the N-terminus Cys1 extension of
tyrosinase are temperature-sensitive mutants and recover enzymatic activity at the permissive temperature of 31uC. Sites s3
and s4 display selective calreticulin binding properties. The C-terminus sites s7 and s6 are critical for the endoplasmic
reticulum retention and intracellular disposal. Results herein suggest that individual N-glycan location is critical for the
stability, regional folding control and secretion of human tyrosinase and explains some tyrosinase gene missense mutations
associated with oculocutaneous albinism type I.
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Introduction
N-glycosylation plays a pivotal role in glycoprotein maturation
and functioning. Bulky N-glycans located at the surface of
secretory and cell membrane glycoproteins molecules are mostly
exposed to the extracellular space. These oligosaccharides serve
multiple functions acting mainly as stabilizers and protective
shields for the glycoprotein outside the cell and as recognition
targets in adhesion and immune response modulation. Neverthe-
less, intracellular membrane glycoproteins facing the lumen of the
subcellular organelles may be heavily glycosylated also, suggesting
specific functions within the cell. The roles of these oligosaccha-
rides in controlling intracellular processes such as folding, sorting
and traffic of proteins have been extensively investigated (reviewed
in [1,2]). There is now clear evidence that N-glycosylation at
distinct sites might perform different and multiple functions along
the protein lifetime [3,4,5, and 6]. Evidence of possible selection
pressure to preserve the N-glycosylation sites comes from the
sequence comparison in many glycoproteins indicating the
existence of conserved sets of N-glycosylation sites [7]. For example,
it has been recently reported that several of the seven conserved N-
glycosylation sites of the tyrosinase family proteins can perform
distinct functions [8]. In the absence of a comprehensive analysis of
human tyrosinase glycosylation, the study suggested that conserved
sites may perform various functions.
The tyrosinase family of genes in vertebrates includes three
related members encoding glyco-enzymes, tyrosinase, tyrosinase-
related protein-1 (TRP-1) and tyrosinase-related protein-2 (TRP-
2). These proteins determine melanin synthesis in pigment cells
and are important players in mammalian pigmentation [9].
Human tyrosinase is a transmembrane glycoprotein with two
copper ions in its active site and six or seven N-linked glycans
exposed towards the lumen of specialized subcellular organelles
called melanosomes [10,11]. Tyrosinase regulates pigmentation by
catalyzing the oxidation of L-tyrosine to L-DOPA which further
initiates a series of oxidation and polymerisation reactions leading
to the synthesis of melanin in melanosomes [12,13]. Although
tyrosinase polypeptide is synthesized at the endoplasmic reticulum
(ER) and its maturation and folding occur within the ER lumen,
the enzyme becomes fully functional only when it reaches the
melanosomes. Hence, its intracellular transport starting from the
ER and passing through the Golgi en route to melanosomes is
tightly regulated at specific stages by multiple processes including
the copper uptake and the N-glycosylation process [14,15].
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become active and this step occurs in the Trans Golgi network and
in melanosomes [15]. The absence of enzymatically active
tyrosinase is the main cause of oculocutaneous albinism IA
(OCA IA). Mutations leading to tyrosinase lacking N-glycans at N-
337 or N-371 were reported in a number of OCA IA patients
[16,17]. Most OCA IA mutations lead to misfolded tyrosinase
which is retained in the ER by the quality control (ERQC) and
subjected to degradation by the ERAD pathway [18,19].
A crucial role in the ERQC is played by calnexin (CNX) and
calreticulin (CRT). These mannose binding lectins assist tyrosinase
during its folding within the ER. We have previously shown that
abolishing CNX association by inhibiting the N-glycosylation
processing or impairing tyrosinase tethering to the membrane
results in a misfolded protein unable to exit the ER [20,21, and
22]. Entry of tyrosinase in the CNX and not CRT cycle is a
decisive event in the formation of native disulfide bonds and
polypeptide folding [23,24]. CNX interacts with tyrosinase co-
translationally following the attachment of its first two N-glycans
during translation and translocation of the polypeptide within the
ER [25]. However, whether the other five N-glycans are required
for this interaction has not been systematically investigated.
Oligosaccharides could be specific recognition elements in the
ERAD pathway. An important component of the ERAD pathway
is EDEM 1, a mannosidase-like chaperone that regulates the
extraction of misfolded polypeptide chains from calnexin cycle and
sends them back to the cytosol for proteasomal degradation
[26,27]. Tyrosinase associates with EDEM1 during the ER
maturation process, but data about the role of individual N-
glycans in this process are rather scarce [28].
In this paper we investigate the role of conserved individual N-
glycans in human tyrosinase maturation and intracellular traffic.
To analyze the localization of N-glycans, a 3D model of the
central active site unit of human tyrosinase was derived based on
the X-ray crystallography data of Streptomyces castaneoglobisporus
tyrosinase. We propose an N-glycan distribution covering two
opposite sides of the molecule, occurring either in the close
proximity or remote of the active site area. While two
oligosaccharides located opposite the active site were specific
CRT targets, glycosylation mutants analysis provided evidence
that a pair of N-glycans covering the active side have been crucial
for its ER export towards the secretory pathway. Moreover, while
the N-terminus N-glycans are required for the early stages of the
folding process, the C-terminus are conditional for completion of
its post-translational productive folding.
Materials and Methods
Reagents, Cell Lines and Antibodies
Human embryonic kidney (HEK 293T) and A375 cells were
obtained from the European Collection of Animal Cell Culture
(Porton Down, UK). Cells were grown in DMEM, respectively
RPMI 160 medium (EuroClone) containing 10% fetal calf serum
(Biochrom), 50 units/mL of penicillin and 50 mg/mL of
streptomycin (Invitrogen) and maintained at 37uC with 5%
CO2. Rabbit anti-calnexin antiserum was a kind gift from Dr.
J.J. Bergeron (McGill University, Canada) and the anti-ERGIC 53
antibody was from Dr. Hans-Peter Hauri (University of Basel,
Switzerland). The mouse monoclonal anti-hemagglutinin antibody
was from Santa Cruz Biotechnology (Santa Cruz, CA). T311
(NeoMarkers, Fremont, CA) is a monoclonal antibody IgG2a
recognizing human tyrosinase. The cDNA encoding the mouse
EDEM fused to an HA-tag in the pCMV-SPORT2 vector was a
kind gift from Prof. K. Nagata and Dr. N. Hosokawa (Institute of
Frontier Medical Science, Kyoto University, Kyoto, Japan).
Kifunensine and lactacystin were from Toronto Chemicals, the
other reagents were from Sigma.
Tyrosinase N-glycosylation mutants
Mutant proteins were obtained based on the human tyrosinase
cDNA expression plasmid, pTriEx-WT obtained previously [24].
Tyrosinase mutants lacking single or multiple N-glycosylation sites
were obtained by changing the codon for Asn (AAT or AAC) from
the glycosylation sequon to the codon for Gln (CAA), either using
a site-directed mutagenesis kit (Clontech, USA) or by three-steps
PCR method. Briefly, in this method, a set of reverse
complementary oligonucleotide primers contained the base
substitutions in the center of the primers. In the first and the
second PCR reactions, these primers were paired with a 39- and
59-primer from the opposite end of the cDNA sequence,
respectively. Then, the DNA sequences synthesized by the first
two PCR reactions were used as template with the end primers for
the third PCR reaction to generate the full-length recombinant
DNA, which was cloned into BamHI/XhoI site of pTriEx1.1.1
vector (Novagen, UK). The sliding glycosylation mutant construct
was obtained based on tyrosinase mutant cDNA D7 with the
following codon changed: Q378N (s7R378). For construction of
the triple mutations D(1,2,3) (N86-N111-N161) and D(5,6,7)
(N290-N337-N371), the mutagenic primers correspond to the
middle glycosylation site; for the first two PCR reactions the
mutants lacking single glycosylation site were used as template.
Unglycosylated mutant Dall was obtained with the mutagenic
primers corresponding to the s4-N230 site based on the cDNA
sequences of D(1,2,3) and D(5,6,7). Nucleotide sequence of all
constructs was confirmed by sequencing.
Transfection of Cells and Metabolic Labeling
Constructs were transiently transfected in HEK 293 and A375
cells. Semi confluent HEK 293 cells (50–70% confluence) 24 h
post-seeding in 6-well dishes were used to transiently express
tyrosinase cDNAs (3 mg of DNA/well) using polyethylenimine
(PEI) solution (1 mg/mL, pH-8; 6 mL of PEI/well, Sigma) and
90% confluent A375 cells were transfected using Lipofectamine
2000 (Invitrogen) using 7.5 mL of Lipofectamine for 3 mg of DNA.
Cells were analyzed 24 h after transfection. For metabolic
labeling, transfected cells were starved in the cysteine – methionine
free medium for 1 h, pulse labeled with 100–150 mCi of [
35S]
methionine/cysteine (MP Biomedicals) for 20 minutes and chased
for the time specified. Immediately after chase cells were harvested
in cold PBS with 20 mM N-ethylmaleimide (NEM). Cells were
then lysed with CHAPS lysis buffer (50 mM HEPES buffer,
pH 7.5, containing 2% CHAPS, 200 mM NaCl and 0.5%
protease inhibitor mixture containing leupeptin, aprotinin, sodium
EDTA, bestatin, 4-(2-aminoethyl) benzene sulfonylfluoride and E-
46) for 1 h on ice. In some experiments lactacystin and kifunensine




35S]-labeled cell lysates were centrifuged, and supernatants
were incubated with T311 antibodies (1:50) overnight at 4uC,
followed by the addition of 20 ml of protein A-Sepharose and
further incubation for 1 h at 4uC. The slurry was washed three
times with 0.5% CHAPS in HEPES buffer. Tyrosinase was eluted
by boiling the slurry for 5 min in SDS sample buffer with 5% 2-
mercaptoethanol or DTT. In some experiments, tyrosinase was
eluted from protein with 1% SDS and the protein was resolved by
SDS-PAGE under non-reducing conditions, i.e. in the absence of
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formed as described previously [24]. Briefly, lysates were
immunoprecipitated with anti-calnexin, and the washed slurry
was eluted with 1% SDS, diluted ten times with lysis buffer, and
re-precipitated with T311 antibodies. The bound proteins were
eluted in reducing conditions and resolved by SDS-PAGE. The
gels were visualized by autoradiography. Relevant bands were
quantified by scanning densitometry. In some experiments, 5 mM
DTT was added to the cell culture medium at the end of the chase
period. After 5 min cells were harvested in cold PBS containing
20 mM N-ethylmaleimide to alkylate the free SH groups and then
lysed as described above.
Immunofluorescence
HEK 293T cells were plated on cover slips and transfected with
different constructs using the methods specified above. For some
experiments cells were incubated with 20 mM nocodazole for 5 h
before fixation. After 24 h the cells were rinsed with PBS and
either fixed with paraformaldehyde (PFA) for 20 min at room
temperature or fixed and permeabilized with methanol at 220uC
for 5 min. After washing three times in PBS, cells were incubated
with the primary antibodies T311 (1:250), CNX (1:200) and
ERGIC-53(1:250) diluted in PBS for 30 min at room temperature.
Following three washes with PBS they were further incubated with
the appropriate Alexa 594-conjugated and Alexa 488-conjugated
secondary antibodies (1:400) in PBS for 30 min at room
temperature. Finally, cells washed three times with PBS were
mounted on cover slips in Vectashield mounting medium
(Invitrogen) and viewed with a Nikon Eclipse E 600 fluorescent
microscope. Images were processed using Adobe Photoshop 5.0
software.
Tyrosinase assay
The DOPA-oxidase assay measured the second major catalytic
reaction of tyrosinase, the conversion of DOPA to DOPAchrome
via DOPAquinone. This reaction was performed in 0.1M
phosphate buffer, pH 6.8 and followed spectrophotometrically
the chromogenic appearance of DOPAchrome from 1 mM
DOPA at 475 nm [21]. Specific activity was measured using the
Western blot quantitation of the actual amount of tyrosinase in the
cell lysate and was calculated as the mean of three independent
assays.
Sequence analysis and Modeling
Tyrosinases were aligned with ClustalW [29]. An intrinsic
disorder score for each position in the sequence was computed
based on intrinsic disorder profiles generated with DisEMBL [30],
IUPRED [31], RONN [32] and FoldIndex [33]. Consensus
secondary structure propensity was determined based on SSPro
[34], Jpred [35], GOR IV, SOPMA and HNN [36]. Other
various physico-chemical sequence profiles were raised with in
house software.
Human tyrosinase was modeled starting from Streptomyces
castaneoglobisporus, pdb code 1wx2 [37]. Refined alignment and
sequence to structure mapping was performed in Insight II and
with Slide, a interactive threading software [38]. Modeling of
sequence conserved regions and variable loop generation were
performed with the Homology module in Insight II software from
Accelrys. Protein model refinement consisted in iterations of local
structure rebuilding followed by energy optimization and model
quality assessment using MetaMQAP [39]. Energy optimization
consisted in repeated rounds of energy minimization, and local
and global simulated annealing performed with Discover in Insight
II using the cvff force field.
The glycan moiety was modeled with Glyco-Pack, a software for
glycoprotein structural analysis and modeling [40] and with
Amber [41]. Five GlcNAc2Man7 N-glycans were attached in silico
to the model of human tyrosinase protein core at glycosylation
sites s3:N161, s4:N230, s5:N290, s6:N337 and s7:N371 in
configurations consistent with the most populated conformer
derived from the SAGS data base of experimental glycoprotein
structures [42]. The glycan attachment, conformational search,
and clash analysis were performed with Glyco-Pack and the
glycoprotein structure was further optimized in Amber 10, using
Glycam 06 and ff99sb force fields [43].
Results
Human tyrosinase 3D modeling
Vertebrate tyrosinases are type I transmembrane proteins of
,530 aa length. Their sequences were historically divided in two
copper domains, Cu A and Cu B, preceded and interposed
respectively by two so called cysteine rich domains, Cys1 and
Cys2, followed by a C-terminal transmembrane and cytosolic
domain, (Fig. 1) [44].
Sequence alignment reveals that the central region of human
tyrosinase (hT: aa 142–450) overlaps with the prokaryal tyrosinase
from Streptomyces castaneoglobisporus (sT) (Fig. 1). This roughly
excludes downstream the Cys1 domain, and upstream the TM
and the cytosolic domains. Within the overlapping region the
overall identity between the target and the template is over 25%,
and the homology is over 55%. Moreover the similarity is
unevenly distributed and it clusters into two main sub-regions of
113aa and 154aa respectively, with over 30% identity and 60%
homology, which are connected by a stretch of 36 aminoacids in
hT (aa272–308), with 14 aa longer that its counterpart in sT. This
makes the region aa142–450 of human tyrosinase to fall into the
generally accepted limits of homology modeling [45].
Model refinement of inserts: aa192–196, aa273–282, aa305–
308 and of the N-terminus region within aa142–170 which
consisted into bringing locally the structure in compliance with the
hT secondary structure prediction, results in an increase of the
overall model accuracy from 3.17 A ˚ to 2.48 A ˚ root mean square
deviation (rmsd), with the global distance test total score raising
from GDT-TS=54.14 to 62.91. The largest local deviation of the
model from an optimal alpha carbon path does not exceed 6 A ˚
rmsd and reach its maximum in the insert aa192–196, a region
that does not inflict on the placement of N-glycans, nor onto the
location of cysteine residues in the Cys2 domain (Fig. 1).
All major intrinsically disorder predictors - FoldIndex, dis-
EMBL, IuPred, RONN etc indicate a high propensity for
flexibility of the hT sequence in the region aa290–315, while the
DLP predictor [46] indicate a high linker propensity in the region
aa283–317. In this regard the five cysteine residues do not fall into
a well defined structural unit. C244, C247 belong to the extended
Cu1, C321 belongs to the extended Cu2, while C276 and C289
are located within the linker. Moreover, the model suggests that
the five cysteine residues are unlikely to form disulfide bonds
between them, and hamper by this the dynamic disorder
propensity of this region. For example the distance between the
closest cysteine residues C276 and C247 is over 19 A ˚ while the
cumulated model rmsd is less than 9 A ˚. It is therefore more likely
that either some of these cysteine residues are involved in disulfide
bridges with cysteine residues from the Cys1 domain, or they
might have only a regulatory protonation role in the melanosomal
environment.
The model hosts also the last five out of seven glycosylation sites
of human tyrosinase, s3:N161, s4:N230, s5:N290, s6:N337 and
N-Glycans Critical for Glycoproteins Maturation
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However, in space they cluster into two pairs: the C-terminal sites
s6 and s7 within the active site region, and s3 and s4 on the
opposite side of the protein. The fifth site, s5:N290, is located into
the linker region, right at the beginning of the most disordered
stretch of human tyrosinase, aa290–315, yet this sequon is
followed immediately by a proline in position 293 (N+3) which
reduces the probability of occupation. The close distance of C-
terminal N-sites s6 and s7 to the active site suggests that their
occupation might influence the local structure and hence the
enzymatic activity more than it does occupation of N-sites s3 or s4.
Assessment of the Cys1 sequence properties failed to result into
a reliable 3D model. Secondary structure predictors pinpoint
along Cys1 four beta strands followed by one helix with 3 or 4
turns toward its C-terminal end. Due to this mainly beta
architecture and to the large number of cysteine residues and
their pattern, the fold recognition predictors such as Phyre [47]
classify the Cys1 domain as belonging with high probability either
to the EGF/laminin (2.10) or to the IG-like (2.60) architectures,
according to CATH [48]. The homology with the closest
templates, 1toz, 2gy5, 2h9e is however less than 15%, at the limit
of statistical noise, and in addition the target-template alignment
do not cover the helical region as well, hence a plausible model of
Cys1 could not be raised starting from these templates.
Nevertheless, we can predict that Cys1 may act as a lid located
on top of the active site unit, in a configuration more or less similar
to that of the caddie protein which co-crystallizes with the sT
template.
The remarkable conservation of the active site area explains the
identity of function between eukarial and prokarial tyrosinases
with eukarial enzyme acquiring during evolution specific molec-
ular determinants such as the Cys1 domain, the TM domain and
the seven N-linked glycans. To further investigate the role of N-
glycans in human tyrosinase function we constructed and
characterized tyrosinase glycosylation mutants.
Enzymatic activity of the N-glycosylation mutants
Single glycosylation mutants (D) at all seven sites, N86, N111,
N161, N230, N290, N337 and N371, two triple mutants D(1,2,3)
and D(5,6,7) and the unglycosylated mutant Dall were constructed
and analyzed in terms of site occupancy, N-glycan processing and
enzymatic activity. The N-glycosylation mutants were expressed in
a previously validated mammalian system using kidney embryonic
cells [23,24, and 49]. In this system, transiently transfected wild
type tyrosinase is translocated into the ER where the glycosylated
polypeptide chain folds in the presence of calnexin/calreticulin
into an export competent protein that exits the ER.
Six out of seven sites were occupied, as seen from the decrease
in mobility caused by the ablation of a consensus site in the single
mutants shown in Fig. 2A and B. No change in mobility was
observed for the D5 mutant expressed either in HEK cells (Fig. 2A)
or in the A375 melanoma cells (supplemental Figure S1)
suggesting that this sequon is rarely occupied in human tyrosinase.
The two triple mutants displayed slightly different molecular
masses corresponding to three (D(5,6,7)) and four (D(1,2,3))
glycans, respectively (Fig. 2B). The unglycosylated mutant
migrated at 60 kDa, corresponding to the polypeptide mass
(Fig. 2B). The faint band migrating above the polypeptide could
represent a minor molecular species with uncleaved signal
sequence.
We further determined the N-glycan processing of the mutants
from EndoH sensitive (sens) structures of high mannose/hybrid
type characteristic to the ER/early Golgi to complex type
structures EndoH resistant (res) acquired within the Golgi.
Expression of wild type tyrosinase in HEK cells yielded an EndoH
sensitive and an EndoH resistant population (Fig. 2A). This is not
surprising, since it has been previously reported that tyrosinase
folding and maturation is rather inefficient resulting in less than
50% of the newly synthesized polypeptide being processed to
EndoH resistant forms [24]. Only the D5 mutant behaved
similarly, while a very faint EndoH resistant form was observed
for D1 (Fig. 2A). All the other mutants were EndoH sensitive (Fig. 2
A). This indicates that all six N-glycans are required for the normal
processing of human tyrosinase. Some minor stringency of s1 N-
glycan may account for the small population of D1 molecules that
are able to mature properly and leave the ER.
To explore the role of the conserved position of the N371 we
further changed the location of s7 in sequence by constructing a
double mutant, N371Q/Q378N. The new selected location was
largely accessible, with no glycan-protein collisions or albino
mutations. As shown in Fig. 2C, the mobility shift of the double
mutant as compared to D7 indicates that the created sequon N378
has been glycosylated within the cell (Fig. 2 C, left panel).
However, the wild type enzymatic activity could not be rescued
(data not shown) and the mutant remained Endo H sensitive
(Fig. 2C, right panel). There is a remarkable stringency for
glycosylation at N371 which is actually the most conserved site in
all species and all members of tyrosinase protein family. Work is in
progress to discriminate between various scenarios explaining this
result and will be described elsewhere (manuscript in preparation).
We have previously shown that wild type tyrosinase trafficking
through the secretory pathway yields a functional protein with
DOPA oxidase activity [20]. The assay of tyrosinase function
revealed that the DOPA oxidase activity of the mutants was
completely abolished in the mutants D6 and D7, dramatically
reduced in the mutants D1, D2, D3, D4 and unchanged in the D5,
which suggests different functions for the individual N-glycans of
tyrosinase (Fig. 2D). The loss of enzymatic activity of the D6 and
D7 mutant correlated with the disruption of their maturation
process. Likewise the partial processing to Golgi structures of wild
type tyrosinase and D5 mutant correlates with their similar
enzymatic activities. The residual activity of the EndoH sensitive
immature D2, D3a n dD4 mutants presented could be due to
post-lysis activation occurring in the presence of DOPA [13],
which may suggest that these immature polypeptides are not
terminally misfolded. To investigate whether the lack of
enzymatic activity was due to folding defects of the polypeptide
we further tested the temperature sensitivity of the mutants. Since
some misfolded tyrosinase mutants may fold and recover their
enzymatic activity below 37uC [24] we have expressed the
mutants in cells cultivated at 31uC. Mutants D1, D2, D3a n dD4
showed a marked increase of their enzymatic activity after 24 h
Figure 1. Restricted 3D model of human tyrosinase. A. Location of the active site region of human tyrosinase (hT) modeled starting from
Streptomyces castaneoglobisporus tyrosinase (sT): extended copper domains Cu A and Cu B are shown in blue and cyan, and the linker is in dark and
light red according to its predicted flexibility. B. The 3D model of hT with its maximal error scale (5 A ˚). Cysteines are in yellow and the position in
space of the unoccupied s5 is shown by one red sugar unit. C. Sequence alignment of hT with sT: cDiso - shows the consensus of predicted hT
disorder, cSS - shows the consensus of predicted hT secondary structure and the RMS - shows the predicted departure of the model from an optimal
path, in Angstroms.
doi:10.1371/journal.pone.0019979.g001
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deletion of any of the four N-terminal N-glycans induces
temperature-sensitive folding defects in tyrosinase. In contrast,
D6 displayed a rather low recovery and D7 was completely
inactive, indicating that the two mutants cannot be rescued by
slowing down the folding process (Fig 2D).
In brief, ablation mutant data show that human tyrosinase has
six N-linked glycans with the s5 sequon unoccupied at least in the
two cell lines tested. The two mutants lacking the N-glycan at the
s6 and s7 C-terminal sites show impaired processing and no
activity. The remaining mutants show intermediate activity,
ranging from 25% to 30%. In addition, these four mutants are
temperature sensitive, in contrast to the couple of C-terminal
mutants that are either low responsive or irreversibly inactive even
at the permissive temperature.
ER retention of the N-glycosylation mutants
The EndoH digestion experiments showed that excepting wild
type and D5 that are processed to significant populations secreted
to the Golgi, the other mutants are mainly EndoH sensitive, which
indicates high mannose ER structures, but also hybrid type N-
glycans occurring within the early Golgi. To confirm the ER
retention or Golgi transport of the glycosylation mutants we
performed co-localization of the mutant tyrosinases with the ER
marker calnexin in immunofluorescence experiments. Wild type
tyrosinase and the D5 mutant co-localized only partially with
calnexin and displayed a cytoplasmic pattern consistent with an
intracellular vesicular distribution (Fig. 3). In contrast, all the other
mutants largely co-localized with the ER marker calnexin,
confirming their ER localization (Fig. 3). These data complete
the N-glycan processing analysis indicating that wild type and the
D5 mutant were partially processed to mature proteins and
secreted from the ER. while all the other single mutants were
mainly retained within the ER at 37uC. At least for the archetypal
mutants, i.e. D5 and the pair D6 and D7, the ER export process
was found to be a pre-requisite for the enzymatic activity,
indicating possible differential functions for individual N-glycans in
tyrosinase traffic.
Association of tyrosinase mutants with calnexin
We and others have previously shown that human tyrosinase
requires CNX/CRT association for proper folding within the ER
[24,25]. The co- and post- translational interaction is transient
with a progressive decrease during tyrosinase ER maturation
accompanied by a parallel increase in the Golgi secreted protein.
To analyze the role of individual glycans in this lectin type
association with calnexin during tyrosinase folding, we made use of
the single N-glycosylation mutants and of the two triple mutants.
The metabolically labeled cells were first immunoprecipitated with
antibodies against CNX or CRT and tyrosinase was recovered
from the complexes by a second immunoprecipitation with anti-
tyrosinase antibody (Fig. 4 and supplemental Figure S2).
Wild type and D5 mutant associated with CNX/CRT in a time-
dependent manner with a maximal association at the beginning of
synthesis. These time course interactions indicate that the
polypeptide associates with the lectin chaperones during the
folding process and gradually dissociates from the native molecules
remaining associated only with the incompletely folded ones. In
contrast, D7 associated with CNX/CRT with a different kinetics
(Fig. 4) since the amount of mutant bound to the lectin increased
during the maturation process, implying that this mutant is unable
to fold properly and it is retained within the cycle before
degradation. The mutants D1, D2, D3, D6 (supplemental Figure
S2) and D4 (Fig. 4) showed less prolonged interactions with CNX,
indicating that they were retained in the CNX cycle less than the
D7 mutant. However, the patterns of association with CNX/CRT
are variable, with the D7 terminally misfolded mutant displaying
the longest retention time. For example, D2 was closest to WT in
terms of CNX interaction. Since this mutant interacted longer
with CRT, the ER retention was driven here by CRT rather than
CNX. Furthermore, retention in CNX cycle is not a simple add up
function with the number of ablated glycan sites, as shown by the
triple mutants D(1,2,3) and D(5,6,7). For example, the mutant
D(1,2,3) dissociated with a rate comparable with WT while mutant
D(5,6,7) had a prolonged interaction with CNX, similar to D7
(Fig. 4). The fast dissociation rate of the D(1,2,3) could be due to its
delivery to the kifunensine dependent degradation pathway which
was markedly different for the two ER retained triple mutants, as
shown below.
Interestingly, little association if any with CRT was found for
the D4 (Fig. 4) and D3 mutants (supplemental Figure S2) up to 2 h
of chase. This indicates that not all N-glycans of newly synthesized
tyrosinase transiently associate with CRT and that s3 and
s4glycans are situated in a region of the molecule accessible to
the lectin CRT.
Disulfide bonds formation during the folding of the D7
mutant
We next examined the disulfide bond formation in wild type
tyrosinase versus the D7 mutant by assessing the accessibility of
these bonds to DTT. Transfected cells were pulsed for 8 min.,
chased for 0, 12 and 20 minutes and incubated or not with 5 mM
DTT before harvesting. We have previously found that this DTT
concentration cleaves only exposed disulfide bonds whereas
completely folded proteins with buried disulfides are unaffected
[23]. Peleted cells were alkylated with 20 mM N-ethylmaleimide
to prevent further oxidation, lysed and immunoprecipitated with
T311 antibody. As previously reported, wild-type tyrosinase
became DTT sensitive at about 12 min chase, as seen from the
slight mobility shift of the DTT treated samples at this chase-point.
A similar increase in the mobility shift was found at 20 min chase
(Fig. 5A). In contrast, the mutant protein D7 followed an
unproductive folding pathway characterized by the formation of
intermediates displaying disulfide bonds accessible to DTT for all
the chase times. This experiment proved that s7 glycan is critical
for the folding process of human tyrosinase since the D7 mutant
was unable to adopt a three-dimensional conformation stabilized
by native disulfide bonds.
ER associated degradation of recombinant tyrosinases
We have further investigated the effect of the proteasomal
inhibitor lactacystin and of the mannosidases inhibitor kifunensin
Figure 2. N-glycan position determines the maturation of tyrosinase mutants. HEK 293 cells were transiently transfected with A) wild type
tyrosinase (WT), D1–D7 single glycosylation mutants, B D(1,2,3), D(5,6,7), Dall mutants and C)WT, D7 and s7378 mutants. 24 h post-transfection cell
lysates were EndoH digested and immunoblotted with anti-tyrosinase antibody. ST-soluble tyrosinase (69 kDa) was used as molecular mass control;
res, the EndoH-resistant secreted forms; sens, the high mannose ER-retained forms. (D)Enzyme activity of the mutants was assayed by measuring
their DOPA oxidase activity at 37uC and 31uC. Data are expressed as percentages of the wild type tyrosinase specific activity and are the averages of
three independent experiments.
doi:10.1371/journal.pone.0019979.g002
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precipitation. As shown in fig. 5B, treatment with both inhibitors
determined the accumulation of the D7 single mutant in the ER.
Similar data were found for wild type tyrosinase (Fig. 5B)
confirming previously reported data and for the other single
mutants (data not shown), thus confirming that all tyrosinase N-
glycosylation mutants are ERAD substrates with proteasomal
degradation. Interestingly, while the triple mutant D(5,6,7) has a
reduced inhibition of degradation in the presence of kifunensine,
the triple mutant D(1,2,3) shows a more pronounced accumulation
of the polypeptide. As a control, we used the non glycosylated
mutant whose degradation at 2 h of chase could not be rescued by
kifunensine treatment (Fig. 5B).
To analyze the interaction of EDEM1 with the mutants, we
have overexpressed EDEM1 and the mutants and immunopre-
cipitated tyrosinase from the cell lysates with anti-tyrosinase
antibodies. As shown in Fig. 5C all single glycosylation mutants
and wild type tyrosinase interacted with EDEM1 (Fig. 5C).
Before secretion, tyrosinase has to pass a post ER check point
in the Golgi which is the decisive step towards secretion versus
recycling back into the ER [50]. In contrast, some OCAI
mutants are retained at the ER without further traffic to the
Golgi compartment and degraded by ER associated degradation
processes [23,24]. To assess the retention process of the N-
glycosylation mutants, we analyzed their co-localization with the
ER-Golgi intermediate compartment (ERGIC) marker, ER-
GIC-53. This mannose lectin transports ER cargo glycoproteins
to the ERGIC and the Golgi [51]. A typical co-localization
experiment is shown in Fig. 6, for wild type tyrosinase (Fig. 6A)
and the D7 mutant (Fig. 6B). Since ERGIC-53 cycles between
the ER, the ER intermediate compartment and Golgi inhibition
of the Golgi to ER pathway in the presence of nocodazole was
shown to arrest the ERGIC-53 within the Golgi, with a visible
change in its subcellular distribution [24,51]. In the absence of
the microtubules-based traffic the population of ERGIC-53
molecules that reached the Golgi displayed a punctuate
distribution outside the ER area. Wild type tyrosinase partially
co-localized with ERGIC-53 within the ER and following the
nocodazole treatment could be seen co-localizing with the
ERGIC-53 even outside the ER. While this confirmed
previously published data, the similar Golgi pattern displayed
by the D7 mutant in the presence of disrupted retrograde
pathway indicates a transport of the misfolded mutant to the
Golgi before its final re-location to the ER and degradation. All
N-glycosylation tyrosinase mutants co-localized with ERGIC-53
in nocodazole treated cells in punctuate structures outside the
ER, (supplemental Figure S3) indicating that the recycling
pathway is common to wild type and all its N-glycosylation
mutants, possibly as part of the ERAD system.
Taken together, the data show that neither the ERAD pathway,
nor the interactions with EDEM1 were dependent on specific N-
glycans. Incompletely folded or misfolded glycosylation mutants
and wild type tyrosinase were recycled between the ER and the
Golgi. However, the C-terminus glycosylation sites were more
exposed to the mannosidase cleavage in the ER than the N-
terminus sites. This indicates a role for the C-terminus glycans in
the disposal of the misfolded tyrosinases through the mannose
timer mechanism.
Discussion
Here we show that tyrosinase individual N-glycans have distinct
roles in folding and maturation depending on their spatial position
relative to the active site region. The pair of N-glycans located in
the proximity of the active site of human tyrosinase, s6:N337 and
s7:N371, irreversibly influence its folding and degradation
processes within the ER. In contrast, the other pair, s3:N161
and s4:N230, located opposite the active site promotes the
association with CRT but not CNX, and their ablation results
only in a reversible inhibition of enzyme activity. The spatial
arrangement of these N-glycans was inferred from a 3D model of
the central, active site region of human tyrosinase (aa: 142 to 450)
derived from Streptomyces castaneoglobisporus tyrosinase with an
accuracy within less than 2.5 A ˚ rmsd. Structural analysis indicates
that rather than consisting in three well separated modules: Cu A,
Cys2 and Cu B the modeled region is actually formed from two
globular domains, ‘extended’ Cu A and Cu B, connected by a
short linker lying within aa 272 to 308. This is predicted to be
flexible by all major intrinsic disorder predictors and this property
may allow the two ‘extended’ copper domains to explore multiple
configurations in order to generate the enzyme active site.
While the modeled region did not include the Cys1 domain with
the first two N-terminal glycans s1:N86 and s2:N111, it contained
the tyrosinase functional unit Cu A-linker-Cu B and the rest of 5
N-glycosylation sites. The model was probed by single and
multiple N-glycosylation mutants and the assessment of their role
in folding, CNX/CRT interactions, ERAD, intracellular traffic
and enzyme activity.
We found that only four of the five modeled sites were actually
occupied, while Asn at site s5 was not glycosylated. This is
consistent with previously reported data [27] and also with the fact
that s5 is not conserved in all tyrosinases. It is absent in dogs, cats,
rodents and fishes, while primates and pigs have proline in position
N+3. A search through the Structural Assessement of Glycosyl-
ation Sites - SAGS database [42] shows that less than 15% of
structurally documented N-glycosylation sites with proline in
position N+3 are occupied. This shows that site s5 is not critical
and the probability to be occupied in human tyrosinase is low.
Interestingly, s5 is highly conserved and it is never followed by a
proline in positon (N+3) in TRP1 and TRP2, confirming the
importance of this site for the other two members of the family
rather than for tyrosinase itself [8].
The four occupied sites are clustered in two groups, the C-
terminal N-sites s6 and s7, located close to the active site, and s3
and s4 on the opposite side of the protein. In sequence these
belong to the extended Cu B and extended Cu A, respectively and
have in common the fact that they are located on bends which
follow or precede regular helices. This is consistent with the very
frequent location of N-glycosylation sites at points where any
change of the local structure of the polypeptide chain is needed.
Such N-sites act as landmarks for ending or starting stretches of
regular secondary structure and increase the folding efficiency
[42].
On the other hand the main structural difference between the
two groups is the proximity to the active site and this remarkably
correlates with the ability of mutants to recover at 31uC. Both
distal N-glycosylation D3 and D4 mutants are not terminally
Figure 3. ER localization of N-glycosylation mutants. Cells were transiently transfected with WT and the single mutants D1–D7. 24 h post-
transfection cells were fixed and permeabilised with methanol and processed for anti- CNX (CNX) and anti-tyrosinase (Tyr) immunofluorescence. The
yellow/orange color in merged images indicates where tyrosinases co-localized with CNX in the ER. A massive overlapping with CNX is present for all
tyrosinases, with some non-overlapping red and green fluorescence for the WT and D5, attributable to non-ER localization.
doi:10.1371/journal.pone.0019979.g003
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properties of temperature sensitive mutants. In contrast the
absence of proximal sites s6 and s7 has far more severe effects
on tyrosinase function. Not only that the activity of D6 and D7
mutants is completely lost, but very low or no recovery is found at
31uC. In addition these C-terminal sites, s6 and s7, are compulsory
for tyrosinase ER maturation since in their absence tyrosinase is
recycled between the ER and Golgi and eventually retained within
the ER and targeted for degradation by EDEM1. The lower
stringency for the presence of distal N-glycans at s3 and s4 is
consistent with the conservation of these sites during evolution. For
example s3 is occasionally missing in tyrosinases or TRP2s of some
Salmonidae and Ictaluridae fishes, and it is always missing from
TRP1s while s4 is absent in some Salmonidae fishes or even some
Bovidae mammals. By contrast s6 and s7 are strictly conserved in
all vertebrate tyrosinases, even though s6 is missing in TRP1 and
TRP2 of some lower species. The fundamental role of s7 is also
indicated by that it is located on a complex loop connecting the
two helices hosting H363, H367, H390 involved copper binding.
Furthermore, as seen from Fig. 5, N-site s7 is in less than 10 A ˚
proximity to the most disordered region of the linker suggesting
that this site might be critical for the quality control system in
monitoring the conformational transitions in the linker region
during the folding process. Naturally occurring mutations at no
less than six locations on this loop, of which two ablate s7, lead to
albino phenotypes, and models indicate that M374, S375 are
involved in catalysis [52]. In addition the D7 mutant adopts a
DTT sensitive conformation unlike the wild type tyrosinase,
suggesting that at least some disulfide bonds remain exposed or
incorrectly formed.
Tyrosinase folding starts co-translationally during the polypep-
tide translocation into the ER lumen. However the completion of
a productive folding requires post-translational steps as previously
reported [23,25]. These consist in the tight regulation of the
polypeptide chain maturation by the quality control system in
which N-glycans play a central role during the entire process.
Previous work focusing on the folding pathways in mouse
tyrosinase N-glycosylation mutants has led to the notion that the
quality control system in the ER operates locally with individual
N-glycans having distinctive roles in glycoprotein folding and that
chaperones associate with and dissociate from the nascent
polypeptide at specific locations and for specific durations in
order to ensure the correct folding of the glycoprotein [20,21].
While CRT role in tyrosinase folding is not completely elucidated,
only minutes amount of the D4 and D3 mutants associated with
CRT, indicating that these two N-glycans are more accessible to
this chaperone. CRT might have a different role then CNX in
tyrosinase maturation, since soluble tyrosinase lacking the TM
domain is unable to undertake a productive folding pathway
despite its CRT association [24]. Our data are in agreement with
the previously published results for another membrane glycopro-
tein, influenza hemmaglutinin whose N-glycans associate with
CRT or CNX depending on their spatial location [4].
The first two N-terminal glycans s1:N81 and s2:N111 that
remained structurally unaccounted in our model are located
within the Cys1 domain, aa20–140, containing an EGF signature
but also a region with high disorder propensity located in-between
aa 38–53. They were shown to mediate tyrosinase co-translational
folding through their interaction with CNX immediately after the
removal of the signal sequence [25]. In contrast the post-
translational folding requires different molecular determinants.
We showed previously the importance of the TM domain in this
process, related to firmly anchoring the polypeptide in the vicinity
of CNX [23]. The data presented here show that in addition to
TM, the C-terminal N-glycans s6:N337 and s7:N371 close in
space to the active site are also strictly required to complete the
post-translational folding of tyrosinase. The prolonged association
with CNX/CRT of the D7 and D(5,6,7) mutants suggests a
different mechanism for preventing tyrosinase exit from the ER.
These oligosaccharides may not be critical CNX targets, but their
deletion could impair the folding of the active site with dramatic
repercussions upon the exposure of hydrophobic patches. The
vital role of s6 and s7 is supported by tyrosinase pathology, since a
number of mutations resulting in their ablation - S339G, N371Y,
N317T, T373K – have been identified in albino phenotypes
[16,17].
All glycosylation mutants are subjected to degradation through
the ERAD pathway with D6 and D7 sharing some peculiarities.
The first step of the intricate timing mechanism for ERAD is the
mannosidase I catalyzed cleavage of a mannose residue of proteins
retained for longer periods within the ER [53,54, and 55]. This is
the signal for the disposal of misfolded proteins in proteasomes.
Our data show that all glycosylation single mutants are targeted
for degradation in proteasomes. All mutants associate with
EDEM1 and accumulate in the presence of the ER mannosidase
inhibitor kifunensine, indicating that the mannoses cleavage could
be a key degradation signal for tyrosinase similar to other proteins
[52,56]. Importantly, the analysis of the cumulative effect of
kifunensine in the triple mutants indicates that the C-terminal
glycans s6 and s7 are more susceptible to mannosidase trimming
than the N-terminal s1, s2, and s3 glycans. Together with the fatal
misfolding caused by the knock down of s6 and s7, these results
suggest that the C-terminus N-glycans drive the ERAD pathway of
tyrosinase and are more readily subjected to ER mannosidase
trimming.
That N-glycans do not play equivalent roles in protein
processing has been shown previously for the cystic fibrosis
membrane conductance regulator, a channel protein involved in
the pathology of the cystic fibrosis [57]. In this case, glycans are
required for calnexin and EDEM binding but not for the channel
function, with the N900 glycan promoting folding and the N894
glycan supporting degradation. Another example is the yeast
carboxipeptidase Y, a soluble glycoprotein with four N-linked
glycans targeted through the Golgi to the yeast vacuole. Only the
C-terminal N-glycan drives the polypeptide into the degradation
pathway, with the N-terminal glycans involved in efficient
intracellular transport [58,59]. Finally, it has been reported that
the apical sorting of the transmembrane cell adhesion molecule
CD 164 was dependent of two of its eight glycans [60].
Taken together the herein data indicate that in contrast to the
glycosylation of distal N-sites, the presence of N-glycans in precise
conserved C-terminal location in close vicinity to the active site is
critical for the correct folding of the enzyme. The absence of post-
translational modification at these locations alters irreversibly the
Figure 4. Association of the N-glycosylation mutants with calnexin and calreticulin. Cells were transiently transfected with WT, D4, D5, D7,
D(1,2,3) and D(5,6,7) mutants. 24 h post-transfection cells were pulsed for 20 minutes and chased for 0, 0.5, 1, 2 hours. Cell lysates were sequentially
precipitated with anti-calnexin or anti-calreticulin and T311 antibodies (Ip CNX, Ip CRT). To determine the total amount of tyrosinase an aliquot of the
lysate was precipitated with T311 antibodies (Ip TYR). Samples were subjected to 10% SDS PAGE and autoradiographed. One of at least two
representative experiments is shown. The ratio CNX (m) and CRT (N) bound tyrosinase/total tyrosinase over time has been plotted.
doi:10.1371/journal.pone.0019979.g004
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PLoS ONE | www.plosone.org 11 May 2011 | Volume 6 | Issue 5 | e19979Figure 5. Misfolded mutants are degraded by ER associated degradation pathways. A. Cells were transiently transfected with WT and the
D7mutant. 24 h post-transfection cells were pulsed for 8 min. and chased for 0, 12 and 20 min. In some samples DTT was added with 5 min. before
harvesting. Cell lysates were immunoprecipitated with T311 antibodies and resolved by non-reducing (NR) and reducing (R) 7.5% SDS PAGE. The
result was visualized by autoradiography. B. Cells were transiently transfected with WT, D7, D(1,2,3), D(5,6,7) and Dall. 24 h post-transfection they
were pulsed for 20 min. and chased for the time indicated in the absence/presence of proteasomal inhibitor lactacystin (Lac) or mannosidase
inhibitor kifunensine (Kif). C. Cells were transiently co-transfected with WT, D1–D7 mutants and EDEM1 (E1). 24 h post-transfection cells were pulse-
chased for 20 min. Cell lysates were precipitated with T311 antibodies. All mutants tested co-immunoprecipitate the EDEM1 protein. One of at least
two representative experiments is shown.
doi:10.1371/journal.pone.0019979.g005
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Supporting Information
Figure S1 The potential glycosylation site s5 is not
occupied in melanoma A 375 cell line. Transfected A375
cells were lysed and postnuclear lysates were subjected to EndoH
digestion and blotted with tyrosinase antibody (T311). The D5
mutant acquires complex glycans resistant to EndoH and migrates
at the same molecular mass as WT tyrosinase.
(TIF)
Figure S2 Association of the D1, D2, D3a n dD6m u t a n t s
with calnexin and calreticulin. Cells were transiently trans-
fected with D1, D2, D3 and D6 mutants. 24 h post-transfection
cells were pulsed for 20 minutes and chased for 0, 30, 60, 120 min.
Cell lysates were sequentially precipitated with anti-calnexin or
anti-calreticulin and T311 antibodies (Ip CNX, Ip CRT). To
determine the total amount of tyrosinase an aliquot of the lysate
was precipitated with T311 antibodies (Ip TYR). Samples were
subjected to 10% SDS PAGE and autoradiographed. One of at
least two representative experiments is shown. The ratio CNX (m)
and CRT (N) bound tyrosinase/total tyrosinase over time has been
plotted.
(TIF)
Figure S3 Traffic of the single N-glycosylation mutants
beyond the ER in the presence of nocodazole. Cells were
transiently transfected with D1–D6 mutants. 5 hours before
immunofluorescence cells were incubated or not with nocodazole
(NOC), fixed and double-labeled with anti-tyrosinase IgG2a (Tyr)
Figure 6. Traffic of the single N-glycosylation mutants beyond the ER in the presence of nocodazole. Cells were transiently transfected
with WT and D7. 5 hours before immunofluorescence cells were incubated or not with nocodazole (NOC), fixed and double-labeled with anti-
tyrosinase IgG2a (Tyr) and anti-ERGIC-53 IgG1 (ERGIC-53) monoclonal antibodies. Alexa Fluor 488 anti-monoclonal IgG1 and Alexa Fluor anti-
monoclonal IgG2a were used as secondary antibodies. The merged images showing co-localization of tyrosinases with ERGIC-53 are also shown.
doi:10.1371/journal.pone.0019979.g006
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PLoS ONE | www.plosone.org 13 May 2011 | Volume 6 | Issue 5 | e19979and anti-ERGIC-53 IgG1 (ERGIC-53) monoclonal antibodies.
Alexa Fluor 488 anti-monoclonal IgG1 and Alexa Fluor anti-
monoclonal IgG2a were used as secondary antibodies. The
merged images showing co-localization of tyrosinases with
ERGIC-53 are also shown.
(TIF)
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